BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18656217)

  • 1. Provision of antiretroviral therapy to children within the public sector of South Africa.
    Bock P; Boulle A; White C; Osler M; Eley B
    Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):905-11. PubMed ID: 18656217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.
    Lawn SD; Myer L; Harling G; Orrell C; Bekker LG; Wood R
    Clin Infect Dis; 2006 Sep; 43(6):770-6. PubMed ID: 16912954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of baseline health and community support on antiretroviral treatment outcomes in HIV patients in South Africa.
    Wouters E; Van Damme W; van Rensburg D; Meulemans H
    AIDS; 2008 Nov; 22(18):2545-8. PubMed ID: 19005281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi.
    Bong CN; Yu JK; Chiang HC; Huang WL; Hsieh TC; Schouten EJ; Makombe SD; Kamoto K; Harries AD
    AIDS; 2007 Aug; 21(13):1805-10. PubMed ID: 17690580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program.
    Jaspan HB; Berrisford AE; Boulle AM
    Pediatr Infect Dis J; 2008 Nov; 27(11):993-8. PubMed ID: 18818556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a file audit to evaluate retention in care and patient outcomes in a programme to decentralise antiretroviral treatment to primary health care facilities in a high prevalence setting in KwaZulu-Natal, South Africa.
    Searle C; Ramkissoon A; Govender T
    Stud Health Technol Inform; 2010; 160(Pt 1):476-80. PubMed ID: 20841732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa.
    Wouters E; Van Loon F; Van Rensburg D; Meulemans H
    AIDS Care; 2009 Nov; 21(11):1401-11. PubMed ID: 20024717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and outcomes of paediatric antiretroviral treatment in South Africa.
    Meyer-Rath G; Brennan A; Long L; Ndibongo B; Technau K; Moultrie H; Fairlie L; Coovadia A; Rosen S
    AIDS; 2013 Jan; 27(2):243-50. PubMed ID: 23014517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.
    Laurent C; Meilo H; Guiard-Schmid JB; Mapouré Y; Noël JM; M'Bangué M; Joko A; Rozenbaum W; Ntoné FN; Delaporte E
    Clin Infect Dis; 2005 Jul; 41(1):108-11. PubMed ID: 15937770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa.
    Igumbor JO; Scheepers E; Ebrahim R; Jason A; Grimwood A
    AIDS Care; 2011 Feb; 23(2):231-6. PubMed ID: 21259136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.
    Rosen S; Ketlhapile M; Sanne I; Desilva MB
    AIDS; 2008 Jul; 22 Suppl 1():S131-9. PubMed ID: 18664945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
    Seminari E; De Silvestri A; Boschi A; Tinelli C
    AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.
    Danel C; Moh R; Chaix ML; Gabillard D; Gnokoro J; Diby CJ; Toni T; Dohoun L; Rouzioux C; Bissagnene E; Salamon R; Anglaret X;
    J Infect Dis; 2009 Jan; 199(1):66-76. PubMed ID: 18986246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
    van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
    Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
    Assefa Y; Kloos H
    Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
    Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E
    Trop Doct; 2008 Jan; 38(1):5-7. PubMed ID: 18302849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.